Pain Mechanisms and Neuroinflammation in OA

Plenary Session 5

Date: Saturday, April 26, 2025
Time: 10:45 AM to 12:15 PM

Description

Moderators:

Anne-Marie Malfait 

Kai Fu 

10:45 AM - 11:25 AM

Neuroinflammation & Pain: Beyond Immune Cells 

Franziska Denk 

11:25 AM - 11:35 AM

085: LEVI-04, A NOVEL NEUROTROPHIN-3 INHIBITOR, SUBSTANTIALLY IMPROVES PAIN AND FUNCTION IN PEOPLE WITH KNEE OSTEOARTHRITIS: A RANDOMISED CONTROLLED PHASE II TRIAL.

Philip G. Conaghan

11:35 AM - 11:45 AM

086: PROTON-SENSING GPR68 REGULATES JOINT ACIDOSIS AND MODULATES INFLAMMATION AND CATABOLISM IN OSTEOARTHRITIS

Colette Hyde

11:45 AM - 11:55 AM

087: MAPPING THE SYNOVIAL INNERVATION OF THE HUMAN KNEE JOINT

Alia Obeidat

11:55 AM - 12:05 PM

088: THE CD13/B1R AXIS MEDIATES SYNOVITIS IN PTOA

Easton Farrell

12:05 AM - 12:07 PM

089: ASSOCIATION OF CENTRAL PAIN SENSITIZATION WITH PREFRONTAL CORTEX ACTIVATION DURING SINGLE- AND DUAL-TASK WALKING IN KNEE OSTEOARTHRITIS

Soyoung Lee

12:07 PM - 12:09 PM

090: THE RELATIONS OF ANALGESIC ANTIDEPRESSANTS USE TO TOTAL JOINT ARTHROPLASTY AMONG OSTEOARTHRITIS PATIENTS COMPARED TO SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN A LARGE PROSPECTIVE COHORT

Zhiqiang Wang

12:09 PM - 12:11 PM

091: COGNITIVE BIAS AND HEURISTICS ARE ASSOCIATED WITH IMPROVEMENT IN KNEE PAIN IN PATIENTS WITH KNEE OSTEOARTHRITIS TREATED WITH OPEN LABEL PLACEBO

Tommy Kok Kok Annfeldt

12:11 PM - 12:13 PM

092: PHASE I/II CLINICAL TRIAL OF ALLOCETRATM CELL THERAPY FOR KNEE OSTEOARTHRITIS: INITIAL EVIDENCE OF RESPONSE TO INFLAMMATION MODULATION

Einat Galamidi

12:13 PM - 12:15 PM Q & A